Towards Healthcare
Europe Biotechnology Market to Grow at 11.30% CAGR till 2034

Europe Biotechnology Market Thrives with Gene Editing and Biopharma

Market insights predict, the Europe biotechnology industry is expected to grow from USD 418.76 billion in 2024 to USD 1208.75 billion by 2034, driven by a CAGR of 11.30%. The presence of a robust biotech hub is driving the Europe biotechnology market. Germany led the market due to the increased investment in infrastructure.

  • Insight Code: 6271
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

FAQ's

The Europe biotechnology market stands at USD 465.87 billion in 2025 and is expected to reach USD 1208.75 billion by 2034, growing at a CAGR of 11.30% from 2024 to 2034.

Germany is currently leading the Europe biotechnology market share 22% due to the broader investment in R&D and government support.

The Europe biotechnology market includes 5 segments, such as by product/service, by technology, by application, by end user, and by country.

Specialty Pharmaceuticals, Medical Biotechnology, Infection Control, and Digitalization & AI are the main areas of focus for Nordic biotech.

EMA, EFSA, GOVERNMENT.NI, UKRI, ERACoBiotech, ICGEB, EU.